Ferrusca Rangel Lizbeth Gabriela

UNIVERSIDAD AUTÓNOMA DE QUERETARO

FACULTAD DE ENFERMERÍA

LICENCIATURA DE ENFERMERÍA

FARMACOLOGÍA II

FERRUSCA RANGEL LIZBETH GABRIELA

GRUPO 3.1

EL USO PROLONGADO DE LOPERAMIDA

Bibliografía:

1.    Brenner D, Sayuk G, Gutman C, Jo E, Elmes SJ, Liu LW, et al. Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study. The American Journal of Gastroenterology [Internet]. 26 de julio de 2019 [citado 15 de agosto de 2019];Publish Ahead of Print. Disponible en: insights.ovid.com

2.    Kohli U, Altujjar M, Sharma R, Hassan S. Wide interindividual variability in cardiovascular toxicity of loperamide: A case report and review of literature. HeartRhythm Case Rep. 14 de enero de 2019;5(4):221-4.

3.    Varghese SP, Kumari P, Wijegunaratne H, Yovankin T, Garlapati V, Koola MM. Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone. Prim Care Companion CNS Disord. 3 de julio de 2019;21(4):0-0.